Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Zydus Lifesciences Limited Press Release Apr 22 2024

· Issued by Zydus Lifesciences Limited via NSE India

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release announcing the launch of Mirabegron Extended-Release Tablets in the US market. The company received final approval from the USFDA for these tablets and is among the first to launch the generic version. Mirabegron is used for treating overactive bladder symptoms and will be manufactured in Ahmedabad, India. This launch is expected to enhance access to the medication for patients in the US and support Zydus's growth plans in the market.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases